Association of polymorphisms in the BDNF, DRD1 and DRD3 genes with tobacco smoking in schizophrenia

Ann Hum Genet. 2010 Jul;74(4):291-8. doi: 10.1111/j.1469-1809.2010.00578.x. Epub 2010 Apr 25.

Abstract

Emerging evidence indicates that the DRD1-BDNF-DRD3 cluster plays an important role in nicotine addiction. We have performed an association analysis of 42 SNPs within these genes with cigarette consumption in a group of 341 schizophrenia patients. The ACCG haplotype consisting of four BDNF markers (Val66Met (rs6265), rs11030104, rs2049045 and rs7103411) showed an association with the risk of smoking (p = 0.0002). Both DRD1 markers tested (rs4532 and rs686) and the DRD3 marker (rs1025398) showed association with quantity of tobacco smoked (p = 0.01, 0.005 and 0.002, respectively). Our findings are preliminary; however, they support the involvement of the DRD1, BDNF and DRD3 genes in smoking behaviour.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain-Derived Neurotrophic Factor / genetics*
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Humans
  • Polymorphism, Single Nucleotide*
  • Receptors, Dopamine D1 / genetics*
  • Receptors, Dopamine D3 / genetics*
  • Risk
  • Schizophrenia / genetics*
  • Smoking / genetics*

Substances

  • Brain-Derived Neurotrophic Factor
  • DRD3 protein, human
  • Receptors, Dopamine D1
  • Receptors, Dopamine D3